MIRATI THERAPEUTICS INC shareholders Q3 2023

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.

MIRATI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$8,712,0002.64%
5AM Venture Management, LLC 192,500$8,385,3002.41%
Casdin Capital, LLC 498,427$21,711,4802.40%
Camber Capital Management LP 1,500,000$65,3402.15%
SILVERARC CAPITAL MANAGEMENT, LLC 150,000$6,534,0001.98%
Orbimed Advisors 1,959,050$85,336,2181.81%
Logos Global Management LP 300,000$13,068,0001.74%
SECTORAL ASSET MANAGEMENT INC 181,904$7,923,7381.54%
Rock Springs Capital Management LP 1,131,207$49,275,3771.32%
Artal Group S.A. 700,000$30,4921.31%
External links

This page lists MIRATI THERAPEUTICS INC's shareholders in Q3 2023. To view MIRATI THERAPEUTICS INC's shareholder history, click here.